EUVIMEDEUVIMED entdecken
Crossref

Increased circulating levels of malondialdehyde-modified low-density lipoprotein in patients with coronary microvascular dysfunction

Tsuyoshi Ito, Masashi Yokoi, Shuichi Kitada, Yu Kawada, Tatsuya Mizoguchi, Shohei Kikuchi, Toshihiko Goto, Yoshihiro Seo

Journal of Clinical Lipidology · 2024

DOI: 10.1016/j.jacl.2024.08.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2024. Verfasst von Tsuyoshi Ito und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan (Drs Ito, Yokoi, Kitada, Kawada, Mizoguchi, Kikuc…. Hauptthemen laut MEDLINE: Lipoproteins, LDL, Malondialdehyde, Coronary Artery Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Coronary microvascular dysfunction (CMD) is associated with angina symptoms and adverse clinical outcomes in patients without obstructive coronary artery disease (CAD). Malondialdehyde-modified low-density lipoprotein (MDA-LDL) is reportedly a marker of the initiation and acceleration of epicardial coronary atherosclerosis. However, its impact on CMD remains unclear. OBJECTIVE: We aimed to investigate the relationship between CMD and MDA-LDL levels. METHODS: This study included 95 patients who did not receive lipid-lowering medications and had no obstructive CAD. Obstructive CAD was defined as >50% diameter reduction on coronary angiography or fractional flow reserve of ≤0.80. We retrospectively analyzed coronary flow reserve (CFR), index of microcirculatory resistance (IMR), and MDA-LDL levels. CMD was defined as either CFR

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoproteins, LDLMalondialdehydeCoronary Artery DiseaseHumansMaleFemaleMiddle AgedAgedMicrocirculationRetrospective StudiesCoronary Angiography

Stichwörter der Autor:innen

Coronary artery diseaseCoronary flow reserveCoronary microvascular dysfunctionIndex of microcirculatory resistanceMalondialdehyde-modified low-density lipoprotein

Substanzen

Lipoproteins, LDLMalondialdehydemalondialdehyde-low density lipoprotein, human

Autor:innen und Institutionen

  • Department of Cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan (Drs Ito, Yokoi, Kitada, Kawada, Mizoguchi, Kikuchi, Goto, and Seo). Electronic address: tuyosiito@gmail.com.
  • Department of Cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan (Drs Ito, Yokoi, Kitada, Kawada, Mizoguchi, Kikuchi, Goto, and Seo).

Zitieren

APA

Ito, T., Yokoi, M., Kitada, S., Kawada, Y., Mizoguchi, T., Kikuchi, S., Goto, T., & Seo, Y. (2024). Increased circulating levels of malondialdehyde-modified low-density lipoprotein in patients with coronary microvascular dysfunction. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2024.08.002

Vancouver

Ito T, Yokoi M, Kitada S, Kawada Y, Mizoguchi T, Kikuchi S, et al. Increased circulating levels of malondialdehyde-modified low-density lipoprotein in patients with coronary microvascular dysfunction. Journal of Clinical Lipidology. 2024. doi:10.1016/j.jacl.2024.08.002

BibTeX
@article{Ito2024,
  author = {Ito, Tsuyoshi and Yokoi, Masashi and Kitada, Shuichi and Kawada, Yu and Mizoguchi, Tatsuya and Kikuchi, Shohei and Goto, Toshihiko and Seo, Yoshihiro},
  title = {Increased circulating levels of malondialdehyde-modified low-density lipoprotein in patients with coronary microvascular dysfunction},
  journal = {Journal of Clinical Lipidology},
  year = {2024},
  doi = {10.1016/j.jacl.2024.08.002}
}
Kostenlos starten →